The Enterprise Value as of December 2025 (TTM) for Advagene Biopharma Co., Ltd. (6709.TWO) is 1.76B

According to Advagene Biopharma Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.76B. This represents a change of 48.89% compared to the average of 1.18B of the last 4 quarters.

Advagene Biopharma Co., Ltd. (6709.TWO) Historical Enterprise Value (quarterly & annually)

How has 6709.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of Advagene Biopharma Co., Ltd. over the last ten years is 1.38B. The current 1.76B Enterprise Value has changed 12.65% with respect to the historical average. Over the past ten years (40 quarters), 6709.TWO's Enterprise Value was at its highest in in the June 2021 quarter at 2.63B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.

Advagene Biopharma Co., Ltd. (6709.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Advagene Biopharma Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Advagene Biopharma Co., Ltd. (6709.TWO) Average Enterprise Value

How has 6709.TWO Enterprise Value performed in the past?

The current Enterprise Value of Advagene Biopharma Co., Ltd. (6709.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Advagene Biopharma Co., Ltd. (6709.TWO) Enterprise Value vs. Peers

How is 6709.TWO’s Enterprise Value compared to its peers?

Advagene Biopharma Co., Ltd.’s Enterprise Value is less than Chunghwa Chemical Synthesis & Biotech Co., Ltd. (2.47B), less than Genomics BioSci & Tech. Co.,Ltd. (2.25B), less than Sunny Pharmtech Inc. (2.44B), less than Greenyn Biotechnology Co., Ltd (2.06B), less than Meribank Biotech Co., Ltd (2.57B), less than Hcmed (2.39B), less than InnoPharmax Inc. (1.83B), less than Shangya Technology Co., Ltd. (2.04B), greater than Enimmune corporation (1.43B), greater than NaviFUS Corp. (1.27B),

Build a custom stock screener for Advagene Biopharma Co., Ltd. (6709.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Advagene Biopharma Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Advagene Biopharma Co., Ltd. (6709.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Advagene Biopharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.